Related Experiment Video
Updated: May 26, 2025

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
Published on: August 16, 2024
Progress of extracellular vesicles-based system for tumor therapy
1MOE Key Laboratory of High Performance Polymer Materials and Technology, College of Engineering and Applied Sciences, Nanjing University, Nanjing 210023, China; Nanjing University (Suzhou) High-tech Institute, Renai Road 150, Suzhou Industrial Park, Suzhou 215123, China.
Extracellular vesicles (EVs) show promise for novel anti-tumor treatments. This review explores natural and artificial EVs as drug delivery systems for cancer therapy, highlighting their potential and challenges.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Oncology
Background:
- Rising global cancer incidence necessitates innovative therapeutic strategies.
- Extracellular vesicles (EVs) are crucial nano-sized mediators of intercellular communication.
- EVs possess inherent properties making them suitable for therapeutic applications.
Purpose of the Study:
- To review the current state of extracellular vesicle (EV)-based tumor treatment methods.
- To discuss the sources, functions, and applications of EVs in cancer therapy.
- To explore the potential of artificial EVs compared to natural EVs.
Main Methods:
- Literature review of recent research on EV-based anti-tumor treatments.
- Analysis of EV characteristics, functions, and therapeutic applications.
- Comparison of natural and artificial EVs for tumor treatment.
Main Results:
- Diverse EVs from various sources exhibit unique properties for anti-tumor applications.
- EVs are effective drug and vaccine delivery carriers, showing satisfactory results in preclinical studies.
- Clinical trials for EV-based tumor therapy are ongoing, demonstrating therapeutic potential.
Conclusions:
- EVs represent a promising platform for developing novel anti-tumor treatments.
- Artificial EVs offer unique advantages over natural EVs for targeted cancer therapy.
- Further research and development are crucial to accelerate the clinical translation of EV-based cancer therapies.

